Ex vivo expansion is being used to increase the number of stem and progenitor cells for autologous cell therapy. Initiation of pivotal clinical trials testing the efficacy of these cells for tissue repair has been hampered by the challenge of assuring safe and high-quality cell production. A strategy is described here for clinical-scale expansion of bone marrow (BM)-derived stem cells within a mixed cell population in a completely closed process from cell collection through postculture processing using sterile connectable devices. Human BM mononuclear cells (BMMNC) were isolated, cultured for 12 days, and washed postharvest using either standard open procedures in laminar flow hoods or using automated closed systems. Conditions for these studies were similar to long-term BM cultures in which hematopoietic and stromal components are cultured together. Expansion of marrow-derived stem and progenitor cells was then assessed. Cell yield, number of colony forming units (CFU), phenotype, stability, and multilineage differentiation capacity were compared from the single pass perfusion bioreactor and standard flask cultures. Purification of BMMNC using a closed Ficoll gradient process led to depletion of 98% erythrocytes and 87% granulocytes, compared to 100% and 70%, respectively, for manual processing. After closed system culture, mesenchymal progenitors, measured as CD105 + CD166 + CD14 − CD45 − and fibroblastic CFU, expanded 317-and 364-fold, respectively, while CD34 + hematopoietic progenitors were depleted 10-fold compared to starting BMMNC. Cultured cells exhibited multilineage differentiation by displaying adipogenic, osteogenic, and endothelial characteristics in vitro. No significant difference was observed between manual and bioreactor cultures. Automated culture and washing of the cell product resulted in 181 × 10 6 total cells that were viable and contained fibroblastic CFU for at least 24 h of storage. A combination of closed, automated technologies enabled production of good manufacturing practice (GMP)-compliant cell therapeutics, ready for use within a clinical setting, with minimal risk of microbial contamination.
INTRODUCTION
. Open cell culture also requires expensive, wellequipped, clean room facilities for good manufacturing practice (GMP) cell production, which are rare. The initiation of large controlled pivotal trials to test potential indications for cell therapy has been hampered, Human bone marrow contains, in addition to cells of lymphoid and myeloid lineages, multiple stem cell in part, by the challenge of attaining a level of quality of cell production to meet regulatory standards for clini-populations, including endothelial progenitors (EPC), hematopoietic stem cells (HPC), and mesenchymal stro-cal trial use (9, 10, 13, 25) . Regulatory requirements include demonstration of a quality control system with a mal cells (MSC). Human bone marrow mononuclear cells (BMMNC) have been used clinically to not only defined work flow, in-process controls, and specific release criteria (8) . Standard "open" cell culture is time reconstitute the hematopoietic system, but to regenerate bone and to treat ischemic tissues as well (19, 32, 33) . In consuming and susceptible to microbial contamination addition, purified stem cell subsets have been used in gether with MSC were stained with CD13-FITC (Beckman Coulter) along with a lineage B (linB) cocktail of cell therapy protocols (4, 14, 20) either directly or after ex vivo expansion. In particular, marrow-derived MSC PE-conjugated antibodies: CD3, CD11b, CD15, CD20, and Gly-A (CD235a) (Beckman Coulter). Erythroid have attracted great interest in tissue regeneration due to their multilineage differentiation potential into bone, cells were assessed by staining with FITC-anti-Gly-A (CD235a). After 15 min cells were washed and resus-cartilage, fat, tendon, muscle, and neural and endothelial cells (15, 21, 24) . However, it has been demonstrated that pended in 0.5 ml PBS/BSA for analysis on the Epics XL-MCL (Beckman Coulter) flow cytometer. Before typical MSC expansion protocols, which include multiple passaging of cells, can lead to genomic instability analysis, samples were incubated with 7-aminoactinomycin D (7AAD) for 5 min at 4°C to assess cell viabil-and deregulation of proliferation (28, 34) .
As an alternative to conventional open cell culture, ity/permeability. a growing number of cell therapy and blood banking Clonogenic Assays technologies are being developed for manipulation of cells in completely closed CE marked systems using CFU-F. Progenitor cell assays were performed in sterile single use consumables (5, 16, 31) . We describe triplicate, using cells harvested before inoculation of the development and validation of a closed production BMMNC and after harvest of the cell product. Briefly, process that is automated and computer controlled, to 1.5 × 10 5 and 3.0 × 10 5 BMMNC or 1 × 10 4 and 2 × 10 4 expand stem and progenitor cells within a mixed populacultivated cells of the cell product were seeded directly tion of BMMNC. In this study, the expansion culture in Base Medium (Aastrom Bioscience, Ann Arbor, MI, was based on long-term bone marrow cultures and con-USA) onto cell culture-treated petri dishes. Base Mesisted of a single-step process without passaging of cells dium consists of Iscove's modified Dulbecco's medium to limit risk of cell transformation. The technology de-(IMDM) with 10% horse serum, 10% fetal bovine sescribed is well suited for GMP-compliant expansion of rum, and 5 µM hydrocortisone. Dishes were incubated stem and progenitor cells within a bone marrow tissue at 37°C in a humidified atmosphere of 5% CO 2 in air for use in cell therapy in regenerative medicine. and cultivated without agitation for 8 days. After removal of medium, cells were stained with Wright's MATERIALS AND METHODS Giemsa for counting (31) . Adherent colonies containing Cell Count more than 20 individual cells were counted as fibroblas-Total WBC cell counts for each bone marrow (BM) tic colony-forming units. Images were digitized using or cell suspension sample were done using either an auan inverted microscope equipped with a CCD camera tomated cell counter, with light scatter and impedance (Nikon, Düsseldorf, Germany). measurement (Cell Dyn 3700, Abbott, Wiesbaden, Ger-CFU-GM. Two thousand cells were inoculated into many), or a Neubauer chamber counting at least 200 the colony assay medium containing 0.9% methylcellu-WBC.
lose (Dow, Midland, MI, USA), 30% fetal bovine se-Flow Cytometry rum, 1% bovine serum albumin, 100 µM 2-mercaptoethanol (Sigma), 2 mM glutamine, and a growth factor mix The samples taken after BMMNC isolation and cell of 10 U/ml erythropoietin, 5 ng/ml G-CSF, and 5 ng/ml product harvest were incubated for 10 min at room tem-IL-3/GM-CSF fusion protein. The assay was done in perature in ammonium chloride to lyse erythrocytes. triplicate using 35-mm non-tissue culture-treated dishes Cells to be analyzed were washed and resuspended in (Nunc, Naperville, IL, USA) for 14 days, under humidi-1× Dulbecco's phosphate-buffered saline (PBS; Gibco) fied conditions, in an atmosphere of 5% CO 2 at 37°C. containing 1% bovine serum albumin. Tubes containing Colonies with more than 50 cells were scored on day 14 10 6 cells in 0.5 ml were stained on ice with various comof culture, using a dark field stereo microscope (Nikon, binations of fluorescent probe-conjugated monoclonal Garden City, NY, USA). antibodies. Mesenchymal stromal cells were stained with CD105-FITC (Serotec), CD166-PE (BD Biosci-Sterility Test ences), and PC5-conjugated anti-CD14 and anti-CD45, (Beckman Coulter). Hematopoietic progenitor cells Sterility assessment was performed from cell suspensions before inoculation, before release of the final cell (HPC) were assessed by staining cells with either CD34-PE (Beckman Coulter) or IgG-PE (control; Beckman product, and from effluent medium 2 days before harvest of the cell product. One milliliter of cell suspension Coulter) monoclonal antibody along with a cocktail of lineage (lin)-specific FITC-conjugated antibodies: CD3, or effluent medium was added to 9 ml of sterile bacterial growth medium (Biomérieux, Nuertingen, Germany) CD11b, CD15, CD20, and glycophorin-A [Gly-A (CD235a)] (Beckman Coulter). Myeloid precursors to-and injected into blood culture Bact/alert FN and FA flasks (Biomérieux). During incubation for 2 weeks at phatase activity using a phosphatase staining kit (Sigma-Aldrich, Taufkirchen, Germany). Images were digitized 37°C, flasks were monitored daily to determine fungal and/or bacterial contamination.
using an inverted microscope equipped with a CCD camera (Nikon, Düsseldorf, Germany). Calcium was Endotoxin Assay quantified following the procedure provided in the Calcium Quantitative Kit (Pointe Scientific Inc., Canton, Endotoxin monitoring was performed using a kinetic chromogenic limulus amoebocyte lysate (LAL) test ac-MI, USA). Briefly, osteogenic cultures were lysed with 0.5 N HCl and lysates were collected into microcentri-cording to the manufacturer's instructions (Cambrex, Verviers, Belgium). Samples of 0.5 ml of effluent me-fuge tubes. After vortexing, each sample was shaken at 500 rpm for 4 h at 4°C. After centrifugation at 1000 × dium were taken 2 days before harvest of cell product and analyzed in duplicate. Endotoxin concentrations g in a microcentrifuge, supernatants were collected and assayed for the presence of calcium by measuring absor-above 0.5 endotoxin units/ml were regarded as positive.
bance at 570 nm.
Differentiation Studies
Induction of tubule formation, as one indicator of en-Closed Process Production of Adult Bone Marrow Stem Cells From BMMNC dothelial differentiation, was performed using Matrigel (BD, Heidelberg, Germany). Matrigel was thawed on ice
The production of autologous stem cell therapeutics to prevent premature gelation; aliquots of 250 µl were is subdivided into four separate steps: aspiration of small plated into individual wells of 24-well tissue culture volume bone marrow, isolation of mononuclear cells plates (Greiner, Frickenhausen, Germany) and allowed from bone marrow, cultivation of mononuclear bone to gel at 37°C for at least 30 min. BMMNC or cells of the marrow cells within a closed bioreactor, and harvest/ cell product (2 × 10 5 ) were seeded on the surface of the purification of the final cell product. extracellular matrix gel and incubated at 37°C for at Bone Marrow Aspiration. Donors were healthy volleast 18 h.
unteers (age 18-45 years) giving informed consent. As-Endothelial progenitor cell (EPC) colonies were meapiration of the posterior ilium was performed under consured following the CFU-Hill procedure from StemCell scious sedation and local anesthetic. After puncture of Technologies Inc. (Vancouver, BC, Canada). Briefly, the iliac crest with a 16-gauge needle, preheparinized cells were plated in fibronectin-coated six-well dishes in 20-ml syringes were used to aspirate 50 ml bone marrow EndoCult Liquid Medium. After 2 days, the nonadherfrom different depths, taking care that on each pull, only ent cells were harvested and plated in fibronectin-coated 2 ml of marrow was removed to minimize inclusion of 24-well plates. After 5 days, the presence of colonies blood. Collected marrow was transferred to a sterile was evaluated.
blood bag with attached luer lock tubing (Miltenyi Bio-Adipogenic differentiation was performed as described tech, Bergisch-Gladbach, Germany) containing 2000 previously (3) . In brief, adipogenic differentiation was units of preservative-free heparin. As bone marrow aspiinduced by cyclic changes of adipogenic induction and ration is the most critical step for risk of microbial conmaintenance medium (Cambrex) in cells grown postcontamination during cell production, puncture was perfluently in 24-well plates (23) . Controls were maintained formed in hygienically monitored rooms with class C in MSC-GM (Cambrex). The induction of adipogenic quality. All further production steps relied completely differentiation was apparent by intracellular accumulaon closed single use systems, using sterile docking techtion of lipid-rich vacuoles that stained with Oil Red O niques. (Fluka, Taufkirchen, Germany). The cells were fixed with 10% formalin, washed, and stained with a working Automatic Isolation of Bone Marrow Mononuclear Cells. Isolation of bone marrow mononuclear cells was solution of 0.18% Oil Red O for 5 min. For the quantitative analysis of the Oil Red O and Fast-Red stained con-achieved with a commercially available system (Sepax S-100, Biosafe, Switzerland) ( Fig. 1a ), which is widely tent in the histological staining, a densitometric analysis was performed using the ImageJ software (National used for isolation of cord blood mononuclear cells prior to cryopreservation (27) . We utilized a novel protocol Institute of Health, USA). The relative content of redstained fractions was determined by color-selective con-(CS-900) that facilitates Ficoll gradient purification to eliminate granulocytes and erythrocytes from bone mar-version of representative red-stained areas and the subsequent analysis of stained pixels. row aspirates. Using a TSCD sterile connect device (Terumo, Leuven, Belgium), four bags were sterilely Osteogenic differentiation was induced by culturing cells of the cell product in osteogenic differentiation me-connected to the Sepax kit: one bag with heparinized bone marrow, one bag with 100 ml Ficoll (density 1.077 dium (Cambrex). After 20 days, osteoblast formation was verified histologically by detection of alkaline phos-g/ml, GE Healthcare, Freiburg, Germany), one bag with 500 ml normal saline supplemented with 0.5% human 5% CO 2 , with a ramped continuous medium perfusion schedule (29) , the cell product, including both nonadher-serum albumin, and one 100-ml blood bag (Baxter, Deerfield, IL USA) for isolated mononuclear cells. Au-ent and adherent cells, was harvested by trypsinization and collected into a harvest bag. All recorded data was tomated BMMNC purification was performed at room temperature for 75 min and 400 × g, followed by two saved on these individual memory devices to comply with GMP-compliant documentation of relevant data washing cycles with albumin-supplemented normal saline resulting in a 50 ml suspension of purified cells. (Fig. 1d ). The bag with purified BMMNC was detached for inocu-Purification and Volume Concentration of the Cell lation into the bioreactor.
Product. Cell culture medium nutrients and components such as animal sera and proteolytic reagent compounds Primary Cultivation of Mononuclear Cells Inside a must be removed or minimized before cells can be given Bioreactor. To increase the number of stem and early to patients. In many cell therapy applications, a small progenitor cells from bone marrow, we used a proprievolume product containing a high dose of cells is retary computer-controlled, automated cell processing quired. Therefore, we used an automated washing sysunit, the Aastrom Replicell System, ARS (Aastrom tem (Cytomate, Baxter, Deerfield, IL, USA) (16) equipped Biosciences, Ann Arbor, MI, USA) ( Fig. 1b ). This syswith single-use sterile kits containing a rotor where cells tem incorporates single-pass perfusion in which fresh can be washed. Washing was done for four cycles using medium flows slowly over cells without retention of 0.5% human serum albumin-supplemented isotonic sowaste metabolites or differentiating cytokines (18) . The lution, and was completed in less than 90 min. Cells medium exchange is independent of gaseous exchange, were collected in an air-permeable bag, and spun down so oxygen can be maintained at a constant 20% at any at 400 × g for 20 min. Cell-free supernatant was dismedium perfusion rate. The cell culture cassette is a carded until only 15 ml cell suspension remained, ready combination of a cell culture flask and a medium reserfor administration to patients. voir, both of which are accessed using sterile connections ( Fig. 1c ). Priming of medium into the cell cassette Manual Isolation of Bone Marrow Mononuclear Cells and inoculation of 200-300 × 10 6 isolated BMMNC was Bone marrow was diluted to 7.5 × 10 6 total cells/ml achieved with the processor (Fig. 1b center) . The culture with isotonic solution containing 0.5% human albumin. medium (Base Medium, Aastrom Biosciences, Inc.) con-
The cell suspension (20 ml) was overlaid on 15 ml Fisisted of IMDM, 10% fetal bovine serum, 10% horse coll (density 1.077 g/ml, GE Healthcare) and centriserum, 5 µM hydrocortisone, gentamycin sulfate, and fuged for 20 min at 25°C and 400 × g. Cells were colvancomycin. Once inoculated, the cell cassette was placed lected from the interface and washed twice with isotonic in a custom incubator constructed in a modular manner solution containing 0.5% human serum albumin. The that controls all environmental conditions (Fig. 1b left) .
same Ficoll preparation was used for both the automated These incubator subsystems (cooling, incubation comand manual systems. partment heating, gas perfusion, and medium perfusion Manual Cultivation of Bone Marrow systems) are controlled by a memory device attached to
Mononuclear Cells the back of the cell cassette. This device controls processor systems for priming, inoculating, and harvesting of BMMNC were purchased from Poietics (Walkersville, MD, USA) and seeded at a density of 3 × 10 5 cells/ the cell cassette. After cultivation for 12 days at 37°C, cm 2 directly in Base Medium (Aastrom Biosciences) BMMNC preparations had a high viability of more than 97%. The presence of hematopoietic progenitor cells onto cell culture-treated petri dishes or flasks. The media used for manual and closed process cultivation were (HPC), measured by expression of the hematopoietic stem cell marker CD34 on lineage-negative cells (no identical with the same serum and antibiotic additives. Cells were incubated at 37°C in a humidified atmo-expression of CD3, CD11b, CD15, CD20, and Gly-A) was evident for 3.6% of total BMMNC; 48.8% of all sphere of 5% CO 2 in air and cultivated for 12 ± 1 days. Cells were fed with 50% medium exchange on days 4, BMMNC belonged to CD13 + /linB − cells, and 15.4% expressed the erythroid marker Gly-A. There were 6.4 per 7, 9, 10, and 11. For each feeding, nonadherent cells were centrifuged and added back to the cultures with the 10 3 BMMNC that grew out as CFU-GM colonies, demonstrating an early myeloid precursor phenotype. Stain-fresh medium. Cultures were harvested by trypsinization on day 12 and cells were counted and evaluated as de-ing of surface markers expressed by mesenchymal stem cells was detected on a small subset of total BMMNC. scribed.
Only 0.03% of cells were positive or double positive for Statistical Analysis CD105 and CD166 and negative for CD14 as well as CD45. In contrast to surface antigen frequencies, estima-Values are given as mean ± SD. Comparisons between groups were analyzed by the nonparametric tion of MSC number by fibroblastic colony formation revealed that only 0.000078% of total BMMNC grew to Mann-Whitney test. A value of p < 0.05 was considered statistically significant. Analyses were done using CFU-F ( Table 2) . Comparison of BMMNC preparations used for inocu-GraphPad Prism 4 Software (GraphPad Software, San Diego, CA, USA).
lation of bioreactor or cell culture plates revealed no significant differences in numbers per square centimeter of RESULTS total cells, CFU-GM, CFU-F, HPC, MSC, or myeloid precursor cells (p > 0.05) ( Table 3) .
Comparison of Automated Versus Manual BMMNC Isolation
Bioreactor Expansion of Mesenchymal Stromal Prior to inoculation, BMMNC were Ficoll isolated and Myeloid Precursor Cells either manually using centrifuge tubes or in a closed system. Recovery of the monocyte/lymphocyte fraction and After isolation, BMMNC were seeded at a density of approximately 3 × 10 5 cells/cm 2 in Base Medium. Culti-depletion of erythrocytes appeared to be slightly better with the manual technique, although the difference was vation was performed for 12 days, which was determined to be the peak for numbers of cycling CD90 + cells not statistically significant (Table 1) . Manually processed cells were more depleted in thrombocytes than as well as the numbers of hematopoietic progenitor and CFU-GM production (data not shown). were cells isolated in the closed system (98.0% vs. 65.8%). In contrast, granulocyte reduction was signifi-Sterility and endotoxin testing revealed no microbiological contamination during the 12-day cultivation pro-cantly better (87 ± 21.7%) using the closed automated Ficoll gradient process than when the manual method cess, and all other in-process controls such as temperature, medium perfusion, and atmospheric conditions was used (69.7 ± 0.4%) ( Table 1) .
were regular as well (data not shown).
Characterization of BMMNC Inoculum
The total number of produced cells in the bioreactor was a mean of 181 × 10 3 (±65.4 × 10 2 )/cm 2 , equal to The mean BMMNC number for inoculation into the automated cell culture system was 238 × 10 6 . All 64% of the starting inoculum. The cell product con- mainly MSC and myeloid precursors ( Table 3 ). The number of cells produced by open cell culture technique was 42% of the original inoculum, and included a 64% decrease in CD13 + /linB − cells. The improved total cell tained predominantly myeloid precursor cells and adherent mesenchymal stromal cells. Numbers of HPC in the number after cultivation in the bioreactor could be attributed to the 1.3-fold expansion of CD13 + /linB − cells. final cell product after automated process was less than 10% of the inoculum (Fig. 2) . The number of CD13 + / This was double that of cells cultured by the manual technique ( Table 2) . Both methods increased CD166 + , linB − cells increased 1.27 (±0.16)-fold from a mean of 1.4 × 10 5 to 1.8 × 10 5 /cm 2 . Bioreactor cultivation in-CD105 + , CD14 − , and CD45 − cells by several hundred fold (Fig. 2) . As shown in Table 3 , there were no signifi-creased CD166 + , CD105 + , CD14 − , and CD45 − MSC by 317-fold (Table 4 ). Colony forming assays were per-cant differences between culture methods in cells staining positive for MSC surface markers (317-fold in bio-formed to identify the potential for self-renewing cells in multiple lineages. Figure 3 shows representative mi-reactor vs. 338-fold in open culture; p > 0.05). CFU-GM decrease was comparable between the two groups (Table crographs of CFU-GM ( Fig. 3A) and CFU-F (Fig. 3B ). The number of CFU-GM was reduced slightly after cul-4). CFU-F number was equivalent and greatly increased in both culture vessels (Fig. 3C ). Increased CFU-F num-tivation, when compared to the original BMMNC (Fig. Numbers of produced MNC, of hematopoietic progenitors (CD34 + /lin − ), of erythroid progenitors (glycophorin-A + ), of myeloid precursor cells together with MSC (CD13+/linB-), and of MSC (CD105 + , CD166 + , CD14 − , CD45 − ) were determined by flow cytometry. CFU-F and CFU-GM were determined by cultural assays as described. The table shows total numbers of cells per square centimeter for the distinct cellular subsets and total colony numbers per square centimeter for the two CFU assays. Values are given for the closed system and for the manual method as mean ± SD. ber from the bioreactor was 364-fold while that of open transcripts specific to osteogenic differentiation, including osteocalcin and osteopontin, were increased (data culture was 366-fold (Table 4) . not shown). Accumulation of lipid-rich vacuoles stained Multilineage Potential of the Cell Products with Oil Red O was apparent in expanded MSC after adipogenic differentiation (Fig. 4D, I) , whereas nonin-To test the differentiation potential and confirm the multilineage potential of the expanded cell product we duced cultures were negative (Fig. 4C, I) . Formation of vascular structures was evident for expanded cells culti-cultured cells after harvesting from the bioreactor in vitro under conditions that favor either osteogenic, adi-vated on collagen gel for 6 h (Fig. 4F ). Also, cell products were collected and differentiated toward endothelial pogenic, or endothelial differentiation (Fig. 4) . After osteogenic differentiation, staining intensity of alkaline cells in EndoCult Liquid Medium (StemCell Technologies) in fibronectin-coated wells. After 5 days, EPC phosphatase activity was more than 250% compared to noninduced controls (Fig 4A, B, G) . Additionally, higher colonies were observed. These colonies contain a central cluster of round cells and elongated spindle-like cells at levels of mineralized matrix as measured by calcium deposition were detected compared to control (Fig. 4H) .
the periphery (Fig. 4E) . These data suggest the potential for endothelial cell induction. RT-PCR has shown that after induction, expression of Fold expansion of cells positive in these assays was calculated by dividing total numbers determined for produced cells through numbers for BMMNC suspension (C).
Storage and Stability of Cell Products
used by standard blood product couriers. Small samples of the cell product were stored in 0.5% human serum albumin-supplemented isotonic solution in air-perme-After harvest, cell products were washed to remove animal proteins to prepare for administration to patients. able bags at 4°C for up to 40 h, and analyzed for vitality and CFU-F number. Viability was 89% for freshly har-Because transportation of stem cell products from a manufacturing site to patient care facilities may require vested cells; total CFU-F number of fresh cells was set to 100% (Fig. 5 ). Storage for 18 h revealed slightly de-cell storage for 24 h or more, we checked the stability of processed cells, when transported under conditions creased viability and a 5% loss in CFU-F number. After 24 h, CFU-F was 85% of the fresh product, and viability for many patients at the same time, frequent manual interventions are required, which may lead to a higher risk was 80% (Fig. 4) .
of microbial contamination. In this context, automation DISCUSSION of cell production might facilitate the wider use of stem cells in clinical trials. Clinical use of stem cells for tissue regeneration to treat previously incurable diseases and conditions is the In enriching bone marrow aspirates for stem and progenitor cells, the automated Ficoll isolation of BMMNC hope of most researchers working with these cells. A major challenge in producing cells for clinical use is the was a simple and easy-to-use method. It eliminated the need for manual interventions or additional equipment, need to implement GMP-compliant production processes to satisfy regulatory requirements. The processes except for a sterile connect device. Recovery of BMMNC was about 50% of all BMMNC in BM, and did not dif-for expansion of stem and progenitor cells up to now have almost completely relied on open preparations with fer significantly from BMMNC obtained by a manual method. The automated procedure has the advantage multiple cell culture flasks or bags (10, 13, 14, 25) . If used can support angiogenesis (1, 26, 35) crucial for important cell therapy applications such as vascular repair or induction of osteogenesis. The MSC within this mixed cell product was functional and active, as evidenced by their proliferative capacity in CFU-F expansion, and multilineage differentiation into osteogenic, adipogenic, and endothelial lineage (11) . In other studies, we have shown that this cell product can also form bone in vivo in an ectopic model for bone formation (6) . Interestingly, the bone-forming potential of this mixed cell product was equivalent to that of more purified typical MSC preparations (data not shown). Additional animal studies are planned to examine the potential of this cell product in other applications including regeneration in ischemic closed processes in this study is that the BMMNC were storage bags. Vitality was assessed by 7-amino-actinomycin D not processed from the same donors. Because donor staining by FACS, and CFU-F recovery was calculated by divariability can be significant, we cannot rule out that the viding total numbers of CFU-F determined for freshly produced cells by numbers of CFU-F found in stored products. magnitude of the differences we report may be modified by donor variability. However, other studies using the same donors for well plates and bioreactors have shown no significant difference in total cell output per square that there is low risk for microbial contaminations. In centimeter (unpublished data). the studies reported here, antibiotics were added to the Our strategy for high-quality stem and progenitor cell culture medium as a prophylactic measure as part of expansion was to utilize single-use materials like blood standard tissue culture practice. However, we have since bags and transfer tubing, as well as closed systems valisuccessfully produced more than 25 lots of cells in the dated in transfusion medicine (5, 16) . This completely automated system in the absence of antibiotics with no closed process abrogates most safety concerns regarding evidence of microbial contamination (unpublished data). microbial contamination, which represents the major Therefore, future trials are planned with antibiotic-free risk in autologous cell use. Using the closed technolomedium to comply with regulatory recommendations. gies described here, it is feasible to plan delivery of bone Depletion of unwanted erythrocytes and thrombocytes marrow and cell products to and from a production facilwas superior with the manual Ficoll isolation; granuloity to the patient care unit to facilitate multicenter pacyte depletion was more effective when the automated tient-specific cell therapy trials. The bioreactor system system was used. Variations in erythrocytes, granuloitself has also been used for closed system expansion of cytes, or thrombocytes of individual donors did not not only BM but umbilical cord blood for allogeneic translate into significant differences in MSC number of stem cell transplants and dendritic cells and T-cells for cell product produced by either method. use in cancer vaccine protocols, showing the versatility BMMNC inoculum contained CD34-positive HPC of this platform technology in producing cell therapeu-(17) but, in agreement with published work, very few tics for a variety of cell types and applications (2,12,22, stromal cell CFU-F (7, 23) . However, MSC expressing 30, 31) . the surface markers CD105 and CD166 increased in cell
In conclusion, we report that a closed cell production culture by several hundred fold; CFU-F assays revealed process is equivalent or better than manual methods, and a high amplification of proliferating MSC, irrespective can be used to provide patients with safe and GMPof the cultivation method used. This suggests that the compliant autologous cell products ready to use in cell bioreactor expansion of MSC, measured as number of therapy trials for tissue regeneration. CFU-F, is at least equivalent to that seen in well plates or flasks.
